The conversations today have been great. You would have to say positive, since positive results seem to be a foregone conclusion & the discussion is mostly about how much profit one should be happy with.I think short-term, sp could spike to levels hard to justify using traditional metrics. Long-term that same sp could prove to be insulting. As to craigakess' point, I would have trouble risking a comfortable retirement($30 plus a share) for a life of excess. I think we know what a great stock & molecule this is, but the sell decision might well be related more to individual circumstances than the true value of the stock.This is not to say that I might not choose to wait.Looking forward to such a scenario. This ain't even regular biotech, let alone regular market. GLTA.